FDA
label_change
· 2021-07-06
FDA Approved: BUPIVACAINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
Summary
FDA approved a supplemental application for Bupivacaine hydrochloride (Hospira, Inc.), indicating a change to the approved product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)